XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 24.91

-1.7%

Dec 18 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (8192)	1/5/1999 1:20:00 PM
From: JOEBT1	Read Replies (2) of 17367

George--I don't follow XOMA as closely as you and others do, but the article I saw on deaths in England cited 280 deaths out of 2800 cases. This is a 10% rather than 20% rate (which XOMA assumed for meningococcemia) thus the number of patients needed for statistical significance would increase. This may explain why the trial went well beyond its original enrollment plans. Can you or Caicito calculate the number of patients needed at the 10% rate.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next